CYNOSURE GETS AN OFFER IT CAN’T REFUSE

Cynosure’s stock jumped 28% after the maker of medical aesthetics systems and technologies announced that it had agreed to be acquired by Hologic in a deal worth $1.65 billion.

To read the full article, click here .